Fundraising Fox
Philip Scheltens
InvestorPartner at EQT Life Sciences
Amsterdam, Netherlands
Writes $11M – $65M checks · typically $25M
Find your path to Philip
Sign up to see every warm intro you have to Philip
- Paths you didn't know you had: your email and LinkedIn already hold routes to Philip. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Philip Scheltens is Partner and Head of the Dementia Fund at EQT Life Sciences, having joined as a Partner at LSP in 2021 before LSP merged with EQT. Before that, he served as Director of the Alzheimer Center at Amsterdam University Medical Center. He is an MD in neurology with a PhD in Medicine from VU University Amsterdam and is Professor of Neurology at Amsterdam University Medical Center.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Investments
Sources: the firm's website · curated public sources.
Colleagues at EQT Life Sciences
Frequently asked questions
- Who is Philip Scheltens?
- Philip Scheltens is Partner and Head of the Dementia Fund at EQT Life Sciences, having joined as a Partner at LSP in 2021 before LSP merged with EQT. Before that, he served as Director of the Alzheimer Center at Amsterdam University Medical Center. He is an MD in neurology with a PhD in Medicine from VU University Amsterdam and is Professor of Neurology at Amsterdam University Medical Center.
- Where does Philip Scheltens work?
- Philip Scheltens is Partner at EQT Life Sciences.
- What does Philip Scheltens invest in?
- Philip Scheltens invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What check size does Philip Scheltens write?
- Philip Scheltens typically writes checks of $11M – $65M.
- What companies has Philip Scheltens invested in?
- Investments tracked here include NewAmsterdam Pharma, Aerska, Asceneuron, Exciva, nobi, Quralis.
- Does Philip Scheltens lead rounds?
- Yes — Philip Scheltens has led 1 tracked investment.
About this profile. Compiled from public sources — EQT Life Sciences's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights